Skip to content
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Medical Genetics · Bardet-Biedl Syndrome Type 9

The Biology of BBS9: Genes and Your Cells

At a Glance

BBS9-related ciliopathy results from disease-causing changes in both copies of the BBS9 gene. These changes disrupt the BBSome, a transport system in primary cilia, interfering with cell signals involved in vision, kidney function, development, and appetite.

To understand Bardet-Biedl Syndrome type 9 (BBS9), it helps to look inside the body’s cells at a structure called the primary cilium. Nearly every cell in the human body has one of these tiny, hair-like projections [1]. You can think of the primary cilium as the cell’s “antenna”—it sits on the surface of the cell, sensing signals from the outside world and sending that information back inside so the cell knows how to grow, move, or function [2].

In BBS9, the genetic change affects how this antenna processes those signals. This page explains the biological machinery behind the diagnosis and how the condition is passed down through families.

The BBSome: A Cellular Delivery Truck

The BBS9 gene (also known as PTHB1) provides the instructions for making a protein that serves as a core part of a machine called the BBSome [3]. The BBSome is made up of eight primary proteins that work together like a delivery truck or a shuttle service [4].

Its job is to move cargo—specifically important signaling proteins—in and out of the primary cilium [5]. When the BBS9 protein is missing or broken, the delivery truck cannot be assembled correctly [3]. As a result:

  • Signals may be disrupted: Proteins involved in pathways like Hedgehog signaling (which helps guide early development) are thought to become disorganized or stuck inside the antenna [2].
  • Cell communication fails: Because the antenna isn’t sending or receiving clear messages, the “instructions” for maintaining vision, kidney health, and weight management become garbled [6]. For instance, it is thought that satiety signals (which tell the body it is full) may not traffic properly through the ciliary pathways, contributing to the intense hunger (hyperphagia) often seen in BBS [5].

Inheriting BBS9: Autosomal Recessive

BBS9 is an autosomal recessive condition [7]. This means that for a person to have the syndrome, they must inherit two pathogenic (disease-causing) copies of the BBS9 gene—one from each biological parent [8].

  • Carriers: Biological parents are typically “carriers.” They have one working copy of the gene and one altered copy. Carriers do not have BBS and usually have no symptoms of the condition [7].
  • The 25% Rule: When both biological parents are carriers, there is a 25% chance with each pregnancy that the child will inherit both altered genes and have BBS9 [9]. There is a 50% chance the child will be a carrier like their parents, and a 25% chance they will inherit two working genes [9].

Geneticists use tests like whole-exome sequencing or multigene panels [10] to identify variants. However, to confirm that there are two variants and that they are “in trans” (meaning they came from different parents rather than being on the same chromosome), parental testing or other phase analysis is often needed [11].

Genotype and Phenotype: A Trend, Not a Rule

A common question is why some individuals with BBS9 have more symptoms than others. This is often related to the type of genetic change (the genotype) and how it affects the final protein (the phenotype), though these are population-level trends and cannot forecast an individual’s exact symptoms.

  • Loss-of-Function Variants: Mutations that completely stop the protein from being made (called nonsense or frameshift mutations) are often associated with the classic, multisystem form of BBS, including vision loss, kidney issues, and extra digits [12][13].
  • Hypomorphic Variants: These are “milder” changes where the protein is still made but doesn’t work perfectly [14]. In some cohorts, these have been associated with milder extra-ocular findings, primarily causing retinal disease, but exceptions are common [14].

Distinguishing BBS from “Look-Alikes”

Because several rare conditions cause weight gain and vision loss, doctors use genetic testing to rule out other diagnoses [15].

  • Alström Syndrome: Like BBS, this causes vision loss and obesity, but it also frequently includes early-onset hearing loss and heart issues (cardiomyopathy) [16], which are less common in BBS [17].
  • Prader-Willi Syndrome (PWS): While PWS also involves intense hunger and weight gain, it is caused by a different genetic mechanism and typically includes severe muscle weakness (hypotonia) in infancy and specific behavioral patterns [18] not usually seen in BBS [19].

By confirming the change is specifically in the BBS9 gene, your care team can focus on the specific monitoring and support needed for this exact condition [9].

Common questions in this guide

What does the BBS9 gene do in the body?
The BBS9 gene provides instructions for a protein that helps form the BBSome, a cellular transport system. The BBSome moves signaling proteins into and out of the primary cilium, helping cells communicate and regulate functions such as vision, kidney health, development, and appetite.
How is BBS9-related ciliopathy inherited?
It follows an autosomal recessive pattern, so a person usually must inherit a disease-causing BBS9 variant from each biological parent. When both parents are carriers, each pregnancy has a 25% chance of BBS9, a 50% chance of carrier status, and a 25% chance of inheriting two working copies.
What does it mean if BBS9 variants are in trans?
Variants are in trans when one altered BBS9 copy came from each biological parent. Parental testing or another phase analysis can help confirm this, which may be important when deciding whether two variants explain the condition.
Can the type of BBS9 variant affect symptoms?
It can be associated with differences in symptoms, but it cannot predict an individual’s exact course. Loss-of-function variants may be linked with the classic multisystem form, while hypomorphic variants may be associated with milder findings in some groups; exceptions are common.
How is BBS9 distinguished from Alström or Prader-Willi syndrome?
Genetic testing can identify whether the change is in BBS9 and help separate BBS9 from similar conditions. Alström syndrome more often includes early hearing loss and cardiomyopathy, while Prader-Willi syndrome has a different genetic mechanism and commonly includes infant hypotonia and characteristic behavior patterns.
What genetic tests are used to diagnose BBS9?
Whole-exome sequencing and multigene panels can identify BBS9 variants. If two variants are found, parental testing or other phase analysis may be needed to determine whether they are on opposite copies of the gene, with one inherited from each parent.

Get notified when new evidence is published on BBS9-related ciliopathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (19)
  1. 1

    Streamlining Diagnosis of Bardet-Biedl Syndrome: New Diagnostic Algorithm With Updated Criteria.

    Pomeroy JJ, Richards J, Sweeney BR, et al.

    American journal of medical genetics. Part A 2026; (200(10)):2181-2198 doi:10.1002/ajmg.a.70199.

    PMID: 42175648
  2. 2

    Requirement of IFT-B-BBSome complex interaction in export of GPR161 from cilia.

    Nozaki S, Castro Araya RF, Katoh Y, Nakayama K

    Biology open 2019; (8(9)) doi:10.1242/bio.043786.

    PMID: 31471295
  3. 3

    Molecular architecture of the Bardet-Biedl syndrome protein 2-7-9 subcomplex.

    Ludlam WG, Aoba T, Cuéllar J, et al.

    The Journal of biological chemistry 2019; (294(44)):16385-16399 doi:10.1074/jbc.RA119.010150.

    PMID: 31530639
  4. 4

    Structural Characterization of Bardet-Biedl Syndrome 9 Protein (BBS9).

    Knockenhauer KE, Schwartz TU

    The Journal of biological chemistry 2015; (290(32)):19569-83 doi:10.1074/jbc.M115.649202.

    PMID: 26085087
  5. 5

    BBS1 is involved in retrograde trafficking of ciliary GPCRs in the context of the BBSome complex.

    Nozaki S, Katoh Y, Kobayashi T, Nakayama K

    PloS one 2018; (13(3)):e0195005 doi:10.1371/journal.pone.0195005.

    PMID: 29590217
  6. 6

    BBS Proteins Affect Ciliogenesis and Are Essential for Hedgehog Signaling, but Not for Formation of iPSC-Derived RPE-65 Expressing RPE-Like Cells.

    Hey CAB, Larsen LJ, Tümer Z, et al.

    International journal of molecular sciences 2021; (22(3)) doi:10.3390/ijms22031345.

    PMID: 33572860
  7. 7

    High prevalence of Bardet-Biedl syndrome in La Réunion Island is due to a founder variant in ARL6/BBS3.

    Gouronc A, Zilliox V, Jacquemont ML, et al.

    Clinical genetics 2020; (98(2)):166-171 doi:10.1111/cge.13768.

    PMID: 32361989
  8. 8

    Identification of a Novel Homozygous Mutation in BBS10 Gene in an Iranian Family with Bardet-Biedl Syndrome.

    Dehani M, Zare-Abdollahi D, Bushehri A, et al.

    Avicenna journal of medical biotechnology 2021; (13(4)):230-233.

    PMID: 34900151
  9. 9

    Bardet-Biedl syndrome improved diagnosis criteria and management: Inter European Reference Networks consensus statement and recommendations.

    Dollfus H, Lilien MR, Maffei P, et al.

    European journal of human genetics : EJHG 2024; (32(11)):1347-1360 doi:10.1038/s41431-024-01634-7.

    PMID: 39085583
  10. 10

    Spectrum of pathogenic variants and high prevalence of pathogenic BBS7 variants in Russian patients with Bardet-Biedl syndrome.

    Orlova M, Gundorova P, Kadnikova V, Polyakov A

    Frontiers in genetics 2024; (15()):1419025 doi:10.3389/fgene.2024.1419025.

    PMID: 39092430
  11. 11

    Clinical and Genetic Characterization of a Russian Family with Bardet-Biedl Syndrome Carrying a Previously Undescribed Missense Variant and a Recurrent Pathogenic Frameshift Variant in BBS7 Gene.

    Nikolaeva AF, Boyko TV, Kadyshev VV, et al.

    Genes 2026; (17(6)) doi:10.3390/genes17060614.

    PMID: 42353774
  12. 12

    Novel homozygous protein-truncating mutation of BBS9 identified in a Chinese consanguineous family with Bardet-Biedl syndrome.

    Tang HY, Xie F, Dai RC, Shi XL

    Molecular genetics & genomic medicine 2021; (9(8)):e1731 doi:10.1002/mgg3.1731.

    PMID: 34212515
  13. 13

    Next-generation sequencing identified novel truncating mutations in BBS9 causing Bardet Biedl syndrome in two Iranian consanguineous families.

    Akbaroghli S, Kooshavar D, Golchehre Z, et al.

    Iranian journal of child neurology 2022; (16(1)):123-133 doi:10.22037/ijcn.v16i1.31650.

    PMID: 35222663
  14. 14

    Autosomal Recessive Rod-Cone Dystrophy with Mild Extra-Ocular Manifestations Due to a Splice-Affecting Variant in BBS9.

    Deitch I, Itskov S, Panneman D, et al.

    Current issues in molecular biology 2024; (46(3)):2566-2575 doi:10.3390/cimb46030163.

    PMID: 38534779
  15. 15

    Bardet-Biedl syndrome: A clinical overview focusing on diagnosis, outcomes and best-practice management.

    Shoemaker A

    Diabetes, obesity & metabolism 2024; (26 Suppl 2()):25-33 doi:10.1111/dom.15494.

    PMID: 38383825
  16. 16

    Identification of Two Cases of Ciliopathy-Associated Diabetes and Their Mutation Analysis Using Whole Exome Sequencing.

    Kim MK, Kwak SH, Kang S, et al.

    Diabetes & metabolism journal 2015; (39(5)):439-43 doi:10.4093/dmj.2015.39.5.439.

    PMID: 26566502
  17. 17

    Searching for Effective Methods of Diagnosing Nervous System Lesions in Patients with Alström and Bardet-Biedl Syndromes.

    Waszczykowska A, Jeziorny K, Barańska D, et al.

    Genes 2023; (14(9)) doi:10.3390/genes14091784.

    PMID: 37761924
  18. 18

    [Prader-Willi syndrome in 2015].

    Tauber M, Thuilleaux D, Bieth É

    Medecine sciences : M/S 2015; (31(10)):853-60 doi:10.1051/medsci/20153110011.

    PMID: 26481024
  19. 19

    Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings.

    Angulo MA, Butler MG, Cataletto ME

    Journal of endocrinological investigation 2015; (38(12)):1249-63 doi:10.1007/s40618-015-0312-9.

    PMID: 26062517

This page is for informational purposes only and does not constitute medical advice. Your genetics team should interpret your BBS9 results and discuss family testing or reproductive options.